Anteris Technologies Global Corp.

NASDAQ:AVR

Medical - Devices

Healthcare
$5.21 -0.16%

-$0.02 today

Market cap
$507.94M
Beta
0.73
P/E (TTM)
-2.3
EPS (TTM)
-$4.04
52W Low $2.85High $10.14

Volume 1.24M

Average 1.18M

AVR Financing Cash Flow

Net cash exchanged with lenders and shareholders through borrowing, repayments, buybacks, and dividends.

Anteris Technologies Global Corp.NASDAQ: AVR

Financing Cash Flow · Q1 FY2026 · quarter ended Mar 2026

Financing cash flow turns positive

Q1 FY2026 financing cash flow was $299.51M, compared with -$1.09M a year earlier. Trailing-twelve-month financing cash flow was $321.16M. Over 3 fiscal years it compounded at -4.1% a year.

Context

  • Financing cash flow amounted to 1074.5% of revenue in FY2025, down 3099.9 pp from a year earlier.
  • Financing cash flow increased in 2 of the last 3 fiscal years.
  • FY2025 was the lowest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly financing cash flow holds near $299.51M or moves back toward the trailing-twelve-month quarterly average of $80.29M.

Sources:Cash FlowText generated from reported figures; not investment advice.

Latest quarterMar 2026
$299.51M+1238.2% QoQ
Last fiscal yearDec 2025
$20.56M-81.8% YoY
LTMMar 2026
$321.16M+191.5% YoY
Financing Cash Flow past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+27552.9%——
1 year-81.8%——
3-year CAGR-4.1%——
5-year CAGR——
10-year CAGR——

Financing Cash Flow history

USD · from the cash flow

Latest · FY2025
20.56M USD
Year-over-year change
-81.8%
4-year CAGR
-6.9%

Financing Cash Flow vs competitors

How AVR compares with its peers on the latest reported figures

  • AVR's LTM Mar 2026 financing cash flow of $321.16M is the 4th largest of the 6 companies compared; the peer median is $958M.
  • Its year-over-year change of +191.5% is the highest of 6, against a peer median of -4.3%.
  • Financing cash flow amounts to 17350.5% of revenue for AVR, versus a peer median of 9.9%.
AVR Competitors Peer median
Financing Cash Flow for AVR and competitors
Company Period LTM YoY 3-year CAGR% of revenue
MDTMedtronic plcLTM Jul 2026$3.71B -25.9%-1.4%9.9%
EWEdwards Lifesciences CorporationLTM Jun 2026$1.2B +4.3%-15.5%18.5%
BSXBoston Scientific CorporationLTM Jun 2026$958M -940.4%-10.3%4.6%
AVRAnteris Technologies Global Corp.LTM Mar 2026$321.16M +191.5%-4.1%17350.5%
LIVNLivaNova PLCLTM Sep 2026$216.48M -4.3%—14.4%
AORTArtivion, Inc.LTM Mar 2026$9.56M +76.9%—2.1%
Peer median (excluding AVR) $958M-4.3%-10.3%9.9%

Competitors are the stored peer set for AVR. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Cash Flow Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Net Income(17.17M)(30.56M)(46.76M)(76.29M)(94.23M)
Depreciation & Amortization640.09K774.08K1.16M1.51M1.66M
Deferred Income Tax00000
Stock-Based Compensation254.85K2.94M5.76M07.78M
Change in Working Capital976.41K(1.75M)3.99M6.69M6.26M
Accounts Receivables85.45K(533.8K)(345.01K)(911K)(515K)
Inventory(15.71K)194.2K(86.73K)(71K)362K
Accounts Payables0007.68M6.42M
Other Working Capital906.67K(1.41M)4.42M00
Other Non-Cash Items861.55K(817.14K)1.23M6.85M715K
Operating Cash Flow(14.44M)(29.42M)(34.63M)(61.24M)(77.8M)
Capital Expenditures(582.24K)(1.67M)(2.39M)(2.27M)(1.95M)
Acquisitions (Net)00(213K)00
Purchases of Investments(311.8K)0000
Sales of Investments00000
Other Investing Activities(1.4K)582.2K19.59K(14K)1.36M
Investing Cash Flow(886.07K)(992.57K)(2.58M)(2.28M)(596K)
Debt Repayment1.74M(975.45K)(808.05K)(2.7M)(1.24M)
Common Stock Issued26.91M25.3M52.82M115.73M23.02M
Common Stock Repurchased00000
Dividends Paid00000
Other Financing Activities(1.23M)(1.05M)(2.68M)(191K)(1.23M)
Financing Cash Flow27.42M23.27M49.34M112.83M20.56M
Effect of Forex Changes6.88K1.04M(390.9K)57K(38K)
Net Change in Cash12.1M(6.1M)11.74M49.37M(57.88M)
Free Cash Flow(15.02M)(31.08M)(37.03M)(63.51M)(79.76M)

Anteris Technologies Global Corp.

NASDAQ:AVR

Intrinsic Alpha fair value

Locked

Current Price

$5.21

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.